Literature DB >> 11274219

Binding of regulator of G protein signaling (RGS) proteins to phospholipid bilayers. Contribution of location and/or orientation to Gtpase-activating protein activity.

Y Tu1, J Woodson, E M Ross.   

Abstract

Regulator of G protein signaling (RGS) proteins must bind membranes in an orientation that permits the protein-protein interactions necessary for regulatory activity. RGS4 binds to phospholipid surfaces in a slow, multistep process that leads to maximal GTPase-activating protein (GAP) activity. When RGS4 is added to phospholipid vesicles that contain m2 or m1 muscarinic receptor and G(i), G(z), or G(q), GAP activity increases approximately 3-fold over 4 h at 30 degrees C and more slowly at 20 degrees C. This increase in GAP activity is preceded by several other events that suggest that, after binding, optimal interaction with G protein and receptor requires reorientation of RGS4 on the membrane surface, a conformational change, or both. Binding of RGS4 is initially reversible but becomes irreversible within 5 min. Onset of irreversibility parallels initial quenching of tryptophan fluorescence (t(12) approximately 30 s). Further quenching occurs after binding has become irreversible (t(12) approximately 6 min) but is complete well before maximal GAP activity is attained. These processes all appear to be energetically driven by the amphipathic N-terminal domain of RGS4 and are accelerated by palmitoylation of cysteine residues in this region. The RGS4 N-terminal domain confers similar membrane binding behavior on the RGS domains of either RGS10 or RGSZ1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274219     DOI: 10.1074/jbc.M101599200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Triacylglycerol mimetics regulate membrane interactions of glycogen branching enzyme: implications for therapy.

Authors:  Rafael Alvarez; Jesús Casas; David J López; Maitane Ibarguren; Ariadna Suari-Rivera; Silvia Terés; Francisca Guardiola-Serrano; Alexander Lossos; Xavier Busquets; Or Kakhlon; Pablo V Escribá
Journal:  J Lipid Res       Date:  2017-06-19       Impact factor: 5.922

2.  Comparative genomics uncovers novel structural and functional features of the heterotrimeric GTPase signaling system.

Authors:  Vivek Anantharaman; Saraswathi Abhiman; Robson F de Souza; L Aravind
Journal:  Gene       Date:  2010-12-20       Impact factor: 3.688

3.  Chronic olanzapine activates the Stat3 signal transduction pathway and alters expression of components of the 5-HT2A receptor signaling system in rat frontal cortex.

Authors:  N A Muma; R K Singh; M S Vercillo; D N D'Souza; B Zemaitaitis; F Garcia; K J Damjanoska; Y Zhang; G Battaglia; L D Van de Kar
Journal:  Neuropharmacology       Date:  2007-07-01       Impact factor: 5.250

4.  Active Galpha(q) subunits and M3 acetylcholine receptors promote distinct modes of association of RGS2 with the plasma membrane.

Authors:  Michael A Clark; Pooja R Sethi; Nevin A Lambert
Journal:  FEBS Lett       Date:  2007-01-26       Impact factor: 4.124

Review 5.  Assembly and trafficking of heterotrimeric G proteins.

Authors:  Yannick Marrari; Marykate Crouthamel; Roshanak Irannejad; Philip B Wedegaertner
Journal:  Biochemistry       Date:  2007-06-09       Impact factor: 3.162

Review 6.  How regulators of G protein signaling achieve selective regulation.

Authors:  Guo-Xi Xie; Pamela Pierce Palmer
Journal:  J Mol Biol       Date:  2006-11-15       Impact factor: 5.469

Review 7.  Regulator of G protein signaling 10: Structure, expression and functions in cellular physiology and diseases.

Authors:  Faris Almutairi; Jae-Kyung Lee; Balázs Rada
Journal:  Cell Signal       Date:  2020-08-31       Impact factor: 4.315

8.  WNK1 promotes PIP₂ synthesis to coordinate growth factor and GPCR-Gq signaling.

Authors:  Sung-Wan An; Seung-Kuy Cha; Joonho Yoon; Seungwoo Chang; Elliott M Ross; Chou-Long Huang
Journal:  Curr Biol       Date:  2011-11-23       Impact factor: 10.834

9.  Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment.

Authors:  G Rivero; A M Gabilondo; J A García-Sevilla; L F Callado; R La Harpe; B Morentin; J J Meana
Journal:  Psychopharmacology (Berl)       Date:  2012-10-24       Impact factor: 4.530

10.  GIPC recruits GAIP (RGS19) to attenuate dopamine D2 receptor signaling.

Authors:  Freddy Jeanneteau; Olivier Guillin; Jorge Diaz; Nathalie Griffon; Pierre Sokoloff
Journal:  Mol Biol Cell       Date:  2004-09-08       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.